Webinar on psychedelics & healing relationships with Dr. Anne Wagner

The publicity for this webinar reads: "These days, we mostly hear about the promise of psychedelics for individuals with depression, PTSD, and other conditions. But for decades, prior to the prohibition of psychedelics and MDMA, these powerful medicines were used in therapy to help improve relationships. Psychedelics have shown promise for healing intimacy and fostering connection with our partners, our family members, our friends, and even people we don’t know at all.

In this 90-minute webinar, Dr. Anne Wagner talks about the latest research into psychedelics for relationships, and how we might use psychedelics to improve our relationships with others. There will also be time for questions from our community at the end." 

Dr. Anne Wagner, C.Psych., is the founder of Remedy, a mental health innovation community, and is the lead investigator of the pilot trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA and the upcoming randomized trial of Cognitive Behavioral Conjoint Therapy for PTSD (CBCT) + MDMA. This work and collaboration builds on the MAPS-sponsored pilot CBCT+MDMA trial she ran with colleagues Michael Mithoefer, MD, Annie Mithoefer, BSN, and Candice Monson, PhD. Anne is deeply committed to bridging the worlds of psychotherapy and non-ordinary states of consciousness, and has a passion for its use for relational healing. She is committed to supporting and protecting traditional and Indigenous wisdom with sacred medicines and consciousness expansion, and uplifting the voices of women in the psychedelic world. She is an Adjunct Professor in the Department of Psychology and an Associate Member of the Yeates School of Graduate Studies at Ryerson University. She is also certified in Mindfulness-Based Cognitive Therapy, and is engaged in learning and practice of somatic, emotion-focused and transpersonal methods of healing. She is the Past-Chair of the Traumatic Stress Section of the Canadian Psychological Association, is a Global Ambassador for the International Society of Traumatic Stress Studies, and sits on the Board of Directors of Casey House (Toronto’s HIV/AIDS Hospital).

Previous
Previous

How ecstasy and psilocybin are shaking up psychiatry.

Next
Next

A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder